270 related articles for article (PubMed ID: 18199157)
1. LKB1 protein expression in neuroendocrine tumors of the lung.
Amin RM; Hiroshima K; Iyoda A; Hoshi K; Honma K; Kuroki M; Kokubo T; Fujisawa T; Miyagi Y; Nakatani Y
Pathol Int; 2008 Feb; 58(2):84-8. PubMed ID: 18199157
[TBL] [Abstract][Full Text] [Related]
2. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of neural-cadherin in pulmonary epithelial tumours.
Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
6. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
7. Expression of nicotinic receptors in normal and tumoral pulmonary neuroendocrine cells (PNEC).
Sartelet H; Maouche K; Totobenazara JL; Petit J; Burlet H; Monteau M; Tournier JM; Birembaut P
Pathol Res Pract; 2008; 204(12):891-8. PubMed ID: 18667281
[TBL] [Abstract][Full Text] [Related]
8. Kit expression in small cell carcinomas of the lung: effects of chemotherapy.
Rossi G; Cavazza A; Marchioni A; Migaldi M; Bavieri M; Facciolongo N; Petruzzelli S; Longo L; Tamberi S; Crinò L
Mod Pathol; 2003 Oct; 16(10):1041-7. PubMed ID: 14559988
[TBL] [Abstract][Full Text] [Related]
9. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
Wang DG; Johnston CF; Sloan JM; Buchanan KD
J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
[TBL] [Abstract][Full Text] [Related]
10. Divergent differentiation in neuroendocrine lung tumors.
Brambilla E; Lantuejoul S; Sturm N
Semin Diagn Pathol; 2000 May; 17(2):138-48. PubMed ID: 10839614
[TBL] [Abstract][Full Text] [Related]
11. Biology and novel therapeutics for neuroendocrine tumors of the lung.
Jafri N; Salgia R
J Biol Regul Homeost Agents; 2004; 18(3-4):275-90. PubMed ID: 15786694
[TBL] [Abstract][Full Text] [Related]
12. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
Folpe AL; Gown AM; Lamps LW; Garcia R; Dail DH; Zarbo RJ; Schmidt RA
Mod Pathol; 1999 Jan; 12(1):5-8. PubMed ID: 9950155
[TBL] [Abstract][Full Text] [Related]
13. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].
Zhao P; Hou N; Shao Y; Li XH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine neoplasms of the lung: a prognostic spectrum.
Asamura H; Kameya T; Matsuno Y; Noguchi M; Tada H; Ishikawa Y; Yokose T; Jiang SX; Inoue T; Nakagawa K; Tajima K; Nagai K
J Clin Oncol; 2006 Jan; 24(1):70-6. PubMed ID: 16382115
[TBL] [Abstract][Full Text] [Related]
16. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung.
Jiang SX; Kameya T; Shinada J; Yoshimura H
Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
18. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas.
Conde E; Suarez-Gauthier A; García-García E; Lopez-Rios F; Lopez-Encuentra A; García-Lujan R; Morente M; Sanchez-Verde L; Sanchez-Cespedes M
Hum Pathol; 2007 Sep; 38(9):1351-60. PubMed ID: 17521700
[TBL] [Abstract][Full Text] [Related]
19. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours.
Kasprzak A; Olejniczak K; Przybyszewska W; Zabel M
Folia Morphol (Warsz); 2007 Aug; 66(3):159-66. PubMed ID: 17985312
[TBL] [Abstract][Full Text] [Related]
20. Paucity of beta 2-microglobulin expression on small cell lung cancer, bronchial carcinoids and certain other neuroendocrine tumors.
Funa K; Gazdar AF; Minna JD; Linnoila RI
Lab Invest; 1986 Aug; 55(2):186-93. PubMed ID: 3525983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
